The close pathological and physiological tie between COPD and metabolic diseases is also revealed in the fact that such systemic inflammation markers as CRP, TNF-a and IL-6 would increase in diabetes and play an important role in the development of diseases. This evidence concerns the gene CRP and metabolic disease.